Port-Site Metastasis after Laparoscopic Biopsy of a Posttransplant Burkitt Lymphoma in a Child

Introduction

Minimally invasive biopsy is playing an increasingly important role in diagnosing pediatric malignancy due to its excellent feasibility, low morbidity, and high accuracy [3], [8]. It has been postulated that minimally invasive techniques and, in particular, the use of CO₂ for pneumoperitoneum, may have an impact on the behavior of macrophages, which are involved in clearing the peritoneal cavity from spilled tumor and other cells [7], and on the behavior of tumor cells themselves [9]. Port-site metastasis in childhood has only been described after resection of pulmonary metastasis of osteogenic sarcoma [10].

References

• 1 Avolio A W, Agnes S, Barbarino R, Magalini S C, Frongillo F, Pagano L, Larocca L M, Pompili M, Caira M, Sollazzi L, Castagneto M. Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series.  Transplant Proc. 2007;  39 1956-1960
• 2 Bonjer H J, Hop W C, Nelson H, Sargent D J, Lacy A M, Castells A, Guillou P J, Thorpe H, Brown J, Delgado S, Kuhrij E, Haglind E, Påhlman L. Transatlantic Laparoscopically Assisted vs. Open Colectomy Trials Study Group. Laparoscopically assisted vs. open colectomy for colon cancer: a meta-analysis.  Arch Surg. 2007;  142 298-303
• 3 Cribbs R K, Wulkan M L, Heiss K F, Gow K W. Minimally invasive surgery and childhood cancer.  Surg Oncol. 2007;  16 221-228
• 4 Curet M J. Port site metastases.  Am J Surg. 2004;  187 705-712
• 5 Iwanaka T, Arai M, Yamamoto H, Fukuzawa M, Kubota A, Kouchi K, Nio M, Satomi A, Sasaki F, Yoneda A, Ohhama Y, Takehara H, Morikawa Y, Miyano T. No incidence of port-site recurrence after endosurgical procedure for pediatric malignancies.  Pediatr Surg Int. 2003;  19 200-203
• 6 Maecker B, Jack T, Zimmermann M, Abdul-Khaliq H, Burdelski M, Fuchs A, Hoyer P, Koepf S, Kraemer U, Laube G F, Müller-Wiefel D E, Netz H, Pohl M, Toenshoff B, Wagner H J, Wallot M, Welte K, Melter M, Offner G, Klein C. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.  J Clin Oncol. 2007;  25 4902-4908
• 7 Metzelder M, Kuebler J F, Shimotakahara A, Chang D H, Vieten G, Ure B M. CO₂ pneumoperitoneum increases survival in mice with polymicrobial peritonitis.  Eur J Pediatr Surg. 2008;  18 171-175
• 8 Metzelder M L, Kuebler J F, Shimotakahara A, Glueer S, Grigull L, Ure B M. Role of diagnostic and ablative minimally invasive surgery for pediatric malignancies.  Cancer. 2007;  109 2343-2348
• 9 Metzelder M L, Kübler J F, Shimotakahara A, Vieten G, von Wasielewski R, Ure B M. CO₂ pneumoperitoneum increases systemic but not local tumor spread after intraperitoneal murine neuroblastoma spillage in mice.  Surg Endosc. 2008; 
• 10 Sartorelli K H, Partrick D, Meagher Jr D P. Port-site recurrence after thoracoscopic resection of pulmonary metastasis owing to osteogenic sarcoma.  J Pediatr Surg. 1996;  31 1443-1444
• 11 Schmidt A I, Reismann M, Kübler J F, Vieten G, Bangen C, Shimotakahara A, Glüer S, Nustede R, Ure B M. Exposure to carbon dioxide and helium reduces in vitro proliferation of pediatric tumor cells.  Pediatr Surg Int. 2006;  22 72-77
• 12 Trappe R, Riess H, Babel N, Hummel M, Lehmkuhl H, Jonas S, Anagnostopoulos I, Papp-Vary M, Reinke P, Hetzer R, Dörken B, Oertel S. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.  Transplantation. 2007;  83 912-918
• 13 Verschuuren E A, Stevens S J, van Imhoff G W, Middeldorp J M, de Boer C, Koëter G, The T H, van Der Bij W. Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication.  Transplantation. 2002;  73 100-104